Phase IIb trial investigating the effects of P1A on gastrointestinal microflora in hospitalised patients treated with IV ampicillin for serious upper- and lower respiratory tract infections
Phase of Trial: Phase II
Latest Information Update: 25 Oct 2007
At a glance
- Drugs P1A (Primary) ; Ampicillin
- Indications Bacterial infections; Intestinal infections; Respiratory tract infections
- Focus Pharmacodynamics
- Sponsors Ipsat Therapies
- 25 Oct 2007 Primary endpoints met; results published in an Ipsat Therapies media release.
- 06 Dec 2006 New trial record.